Correlation of polymorphisms in apoptosis-associated genes FAS and FASL to the risk of gastric cardiac adenocarcinoma

Chinese Journal of Cancer Prevention and Treatment

Volumn 17, Issue 20, 2010, Pages

  Zhou, Rong Miao ^a   Wang, Na ^a   Sun, Dong Ian ^a   Duan, Ya Nan ^a   Huo, Xiang Ran ^a   Guo, Ji Hong ^b   Li, Yan ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Qinhuangdao Branch of North China   (China)

Author keywords

FAS; FASL; Gastric cardiac adenocarcinoma; Polymorphism; Susceptibility

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

AGE DISTRIBUTION; APOPTOSIS; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARDIA CARCINOMA; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

EID: 78751540012     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Huang Q R, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene [J]. Mol Immunol, 1997, 34 (8-9): 577-582.
2. Sibley K, Rollinson S, Allan J M, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia[J]. Cancer Res, 2003, 63 (15): 4327-4330.
3. Wu J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients [J]. J Immunol, 2003, 170 (1): 132-138.
4. Lima L, Morais A, Lobo F, et al. Association between FAS polymorphism and prostate cancer development [J]. Prostate Cancer Prostatic Dis, 2008, 11 (1): 94-98.
5. Zhang B, Sun T, Xue L, et al. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer [J]. Carcinogenesis, 2007, 28 (5): 1067-1073.
6. Li C, Larson D, Zhang Z, et al. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma [J]. Pharmacogenet Genomics, 2006, 16 (4): 253-263.
7. Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma [J]. J Natl Cancer Inst, 2004, 96 (13): 1030-1036.
8. Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated Cells [J]. Nucleic Acid Res, 1988, 16 (3): 1215.
9. Zhang Z, Wang L E, Sturgis E M, et al. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck [J]. Clin Cancer Res, 2006, 12 (18): 5596-5602.
10. Devesa S S, Blot W J, Fraumeni J F Jr. Changing patterns in the incidance of esophageal and gastric carcinoma in the United States [J]. Cancer, 1998, 83 (10): 2049-2053.
11. Botterweck A A, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in the European countries [J]. Im J Epidemiol, 2000, 29 (4): 645-654.
12. Fielding JWL, Powell J, Allum W H. Cancer of the Stomach [M]. London, The Macmillan Press, 1989.
13. Que F G, Gores G J. Cell death by apoptosis, basic concepts and disease relevance for the gastroenlerologist [J]. Gastroenterology, 1996, 110 (4): 1238-1243.
14. Yang M, Sun T, Wang L, et al. Functional variants in cell death pathway genes and risk of pancreatic cancer [J]. Clin Cancer Res, 2008, 14 (10): 3230-3236.
15. Crew K D, Gammon M D, Terry M B, et al. Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk [J]. Carcinogenesis, 2007, 28 (12), 2548-2551.
16. Zhang H, Sun X F, Synnerstad I, et al. Importance of FAS1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis [J]. Cancer J, 2007, 13 (4): 233-237.
17. Park S H, Choi J E, Kim E J, et al. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population [J]. Lung Cancer, 2006, 54 (3): 303-308.
18. Ter-Minassian M, Zhai R, Asomaning K, et al. Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer [J]. Carcinogenesis, 2008, 29 (11): 2147-2152.
19. Wang M, Wu D, Tan M, et al. FAS and FAS ligand polymorphisms in the promoter regions and risk of gastric cancer in Southern China [J]. Biochem Genet, 2009, 47 (7-8): 559-568.
20. Kanemitsu S, Ihara K, Saifddin A, et al. A functional polymorphism in Fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus [J]. J Rheumatol, 2002, 29 (6): 1183-1188.